GROUP ONE TRADING, L.P. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is and the CUSIP is 90400D908. A total of 4 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$57,040
-73.7%
1,600
-66.0%
0.00%
-100.0%
Q2 2023$216,811
-48.6%
4,700
-48.4%
0.00%0.0%
Q4 2022$421,603
+502.3%
9,100
+435.3%
0.00%
Q3 2022$70,000
+94.4%
1,700
+183.3%
0.00%
Q2 2022$36,000
+350.0%
600
+500.0%
0.00%
Q4 2021$8,000
-20.0%
1000.0%0.00%
Q2 2021$10,000
-28.6%
1000.0%0.00%
Q4 2020$14,000
-39.1%
100
-66.7%
0.00%
Q2 2020$23,000
-86.7%
300
-88.0%
0.00%
-100.0%
Q1 2019$173,000
-81.6%
2,500
-79.7%
0.00%
-71.4%
Q3 2018$939,000
+616.8%
12,300
+623.5%
0.01%
+600.0%
Q2 2018$131,000
+2520.0%
1,700
+1600.0%
0.00%
Q1 2018$5,0000.0%1000.0%0.00%
Q4 2017$5,000
-94.6%
100
-93.3%
0.00%
-100.0%
Q2 2017$93,000
-54.2%
1,500
-50.0%
0.00%
-50.0%
Q1 2017$203,000
-69.9%
3,000
-68.8%
0.00%
-71.4%
Q4 2016$675,000
+143.7%
9,600
+146.2%
0.01%
+133.3%
Q3 2016$277,000
+5440.0%
3,900
+3800.0%
0.00%
Q2 2016$5,000
-16.7%
1000.0%0.00%
Q1 2016$6,000
-98.9%
100
-97.9%
0.00%
-100.0%
Q4 2015$527,000
+65.7%
4,700
+42.4%
0.01%
+50.0%
Q3 2015$318,000
+7.1%
3,300
+13.8%
0.00%0.0%
Q2 2015$297,000
-44.4%
2,900
-66.3%
0.00%
-50.0%
Q1 2015$534,000
+662.9%
8,600
+437.5%
0.01%
+700.0%
Q4 2014$70,000
-52.4%
1,600
-38.5%
0.00%
-50.0%
Q3 2014$147,0002,6000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 600$36,0000.00%
JANE STREET GROUP, LLC 6,100$364,0000.00%
SIMPLEX TRADING, LLC 300$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders